Chen Y, Teng F Y H, Tang B L
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore.
Cell Mol Life Sci. 2006 Jul;63(14):1649-57. doi: 10.1007/s00018-006-6019-5.
Multipotent adult stem cells capable of developing into particular neuronal cell types have great potential for autologous cell replacement therapy for central nervous system neurodegenerative disorders and traumatic injury. Bone marrow-derived stromal mesenchymal stem cells (BMSCs) appear to be attractive starting materials. One question is whether BMSCs could be coaxed to differentiate in vitro along neuronal or glial lineages that would aid their functional integration post-transplantation, while reducing the risk of malignant transformation. Recent works suggest that BMSCs could indeed be differentiated in vitro to exhibit some cellular and physiological characteristics of neural cell lineages, but it is not likely to be achievable with simple chemical treatments. We discussed recent findings pertaining to efforts in neuronal differentiation of BMSCs in vitro, and results obtained when these were transplanted in vivo.
能够发育成特定神经元细胞类型的多能成体干细胞在中枢神经系统神经退行性疾病和创伤性损伤的自体细胞替代治疗中具有巨大潜力。骨髓来源的基质间充质干细胞(BMSCs)似乎是有吸引力的起始材料。一个问题是,能否诱导BMSCs在体外沿着神经元或神经胶质谱系分化,这将有助于它们在移植后的功能整合,同时降低恶性转化的风险。最近的研究表明,BMSCs确实可以在体外分化,表现出神经细胞谱系的一些细胞和生理特征,但简单的化学处理不太可能实现这一点。我们讨论了有关BMSCs体外神经元分化的最新研究结果,以及将这些细胞移植到体内时获得的结果。